Calidi Biotherapeutics, Inc. (CLDWW) Operating income 2022–2025
Calidi Biotherapeutics, Inc. (CLDWW) annual operating income history from SEC filings — each fiscal year as reported.
-$20.2MFY2025 · since FY2022: -$23.1M → -$20.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.2M | +7.1% |
| FY2024 | -$21.8M | +24.9% |
| FY2023 | -$29.0M | -25.4% |
| FY2022 | -$23.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLDWW financial trends
CLDWW RevenueCLDWW Net incomeCLDWW Net marginCLDWW Gross profitCLDWW Gross marginCLDWW Operating marginCLDWW Operating cash flowCLDWW Free cash flowCLDWW Capital expendituresCLDWW Return on equityCLDWW Stock buybacksCLDWW Dividends paidCLDWW Total assetsCLDWW Total liabilitiesCLDWW Shareholders’ equityCLDWW overview →